Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01081912 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
A Phase 3 study, sponsored by Zogenix.
- Completed
- Registry status
- Phase 3
- Development phase
- 510
- Enrollment target
NCT01081912 is a Phase 3 study that has completed, run by Zogenix. The registered enrollment target is 510 participants.
The verdict
NCT01081912, a Phase 3 study, has completed, sponsored by Zogenix.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 510 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of Hydrocodone Bitartrate controlled-release capsules in subjects with chronic low back pain.
Interventions
- DRUG Placebo
- DRUG Hydrocodone bitartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01081912
The ClinicalTrials.gov registry entry for NCT01081912 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zogenix, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01081912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01081912 about?
NCT01081912 is a clinical study titled "Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain". The purpose of the study is to evaluate the safety and efficacy of Hydrocodone Bitartrate controlled-release capsules in subjects with chronic low back pain.
What is the current status of trial NCT01081912?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 510 participants. The study started on 2010-03. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01081912?
The interventions under investigation include: Placebo (DRUG), Hydrocodone bitartrate (DRUG).
Who is sponsoring clinical trial NCT01081912?
This trial is sponsored by Zogenix, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.